Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 909.3M | $ 114.9M | 12.64% |
3/31/2025 | $ 1B | $ 81M | 8.09% |
12/31/2024 | $ 1.09B | $ 100.5M | 9.21% |
9/30/2024 | $ 1.17B | $ 85.2M | 7.3% |
6/30/2024 | $ 1.28B | $ 160.3M | 12.53% |
3/31/2024 | $ 1.21B | $ 93.5M | 7.71% |
12/31/2023 | $ 1.3B | $ 317.2M | 24.31% |
9/30/2023 | $ 1.06B | $ 119.2M | 11.26% |
6/30/2023 | $ 1.08B | $ 96.1M | 8.87% |
3/31/2023 | $ 1.18B | $ 135.7M | 11.54% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ARVINAS INC is calculated as follows: CashnEq [ $ 88.99M ] / Assets [ $ 271.95M ]
(=) Cash to Assets [ 32.72% ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.89% |
average | 9.83% |
median | 6.45% |
std | 9.61% |